QUANTUM CAPITAL MANAGEMENT - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 46 filers reported holding PSYCHEMEDICS CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
QUANTUM CAPITAL MANAGEMENT ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2019$788,000
-21.5%
56,179
-11.2%
0.42%
-27.3%
Q4 2018$1,004,000
-17.8%
63,246
-2.7%
0.58%
+33.4%
Q3 2018$1,222,000
+25.7%
64,986
+28.6%
0.44%
+17.2%
Q2 2018$972,000
-3.6%
50,521
+7.0%
0.37%
+53.5%
Q1 2018$1,008,000
+3.8%
47,2050.0%0.24%
+4.7%
Q4 2017$971,000
+71.9%
47,205
+53.9%
0.23%
+73.1%
Q3 2017$565,00030,6690.13%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2017
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders